Taneli Jouhikainen

2019

In 2019, Taneli Jouhikainen earned a total compensation of $1M as Chief Operating Officer & President at Mast Therapeutics, a 74% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$201,338
Option Awards$240,941
Salary$546,000
Other$22,000
Total$1,010,279

Jouhikainen received $546K in salary, accounting for 54% of the total pay in 2019.

Jouhikainen also received $201.3K in non-equity incentive plan, $240.9K in option awards and $22K in other compensation.

Rankings

In 2019, Taneli Jouhikainen's compensation ranked 9,213th out of 13,971 executives tracked by ExecPay. In other words, Jouhikainen earned more than 34.1% of executives.

ClassificationRankingPercentile
All
9,213
out of 13,971
34th
Division
Manufacturing
3,688
out of 5,695
35th
Major group
Chemicals And Allied Products
1,399
out of 2,194
36th
Industry group
Drugs
1,192
out of 1,880
37th
Industry
Pharmaceutical Preparations
885
out of 1,392
36th
Source: SEC filing on April 15, 2020.

Jouhikainen's colleagues

We found two more compensation records of executives who worked with Taneli Jouhikainen at Mast Therapeutics in 2019.

2019

Robert Neville

Mast Therapeutics

Chief Executive Officer

2019

David Lowrance

Mast Therapeutics

Chief Financial Officer

News

You may also like